Approximately 5% of the world-wide population is affected by autoimmune diseases.
Overall, autoimmune diseases are still difficult to treat, impose a high burden on patients …

Skin diseases affect one-third of the global population, posing a major healthcare burden.
Deep learning may optimise healthcare workflows through processing skin images via …

Oral lichen planus (OLP) is a chronic inflammatory disease of the oral mucosa. Several
clinical subtypes of OLP have been reported, including the reticular and erosive one. On the …

Lichen planus is a chronic disease affecting the skin, appendages, and mucous
membranes. A cutaneous lichen planus is a rare disease occurring in less than 1% of the …

The stratum corneum (SC) and cell membrane are two major barriers that hinder the
therapeutic outcomes of transdermal drug delivery for the treatment of skin diseases. While …

Hidradenitis Suppurativa (HS) is a chronic inflammatory skin disease of the pilosebaceous
unit, clinically consisting of painful nodules, abscesses, and sinus tracts mostly in, but not …

The aryl hydrocarbon receptor (AhR) is a ligand-dependent transcription factor that has wide-
ranging roles, including regulation of inflammation and homeostasis. AhR is not a cell …

Regulatory T cell (Treg) impairment is implicated in the pathogenesis of chronic
inflammatory diseases, but relatively little is known about the therapeutic potential of Treg …

Systemic inflammation plays a central role in the pathophysiology of psoriasis. This study
examined accessible systemic inflammatory markers in patients with psoriasis vulgaris and …

Hidradenitis suppurativa (HS), also known as acne inversa, is a chronic disabling and
debilitating inflammatory disease with a high unmet medical need. The prevalence of HS …